Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketomed is a topical antifungal combination product containing ketoconazole and vitamin E, developed and marketed by Med Manor Organics. It is formulated as a medicated soap (often referred to as Ketomed Soap or Ketomed Plus Soap) primarily indicated for the treatment and prevention of various fungal skin infections, including athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis), and seborrheic dermatitis. Ketoconazole, an imidazole antifungal agent, works by inhibiting the fungal enzyme lanosterol 14-alpha demethylase, thereby disrupting ergosterol synthesis and compromising fungal cell membrane integrity. Vitamin E is included as an antioxidant to protect the skin from oxidative damage, reduce irritation, and maintain skin health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ketoconazole + vitamin E.